Neurokinin‑1 receptor antagonist aprepitant and radiotherapy, a successful combination therapy in a patient with lung cancer: A case report-Reference-Cited by-同舟云学术

Neurokinin‑1 receptor antagonist aprepitant and radiotherapy, a successful combination therapy in a patient with lung cancer: A case report

Published:2019-05-10 Issue: Volume: Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:mol clin onc

Author:

Mu�oz Miguel¹,Crespo Juan²,Crespo Jos�³,Cove�as Rafael⁴

Affiliation:

1. Research Laboratory on Neuropeptides (IBIS), Virgen del Roc�o University Hospital, 41013 Sevilla, Spain

2. Department of Pharmacology, Pediatric and Radiology, University of Sevilla, 41009 Sevilla, Spain

3. SEVISTON Laboratory Pathology, 41001 Sevilla, Spain

4. Institute of Neurosciences of Castilla y Le�n (INCYL), Laboratory of Neuroanatomy of the Peptidergic Systems (Lab. 14), University of Salamanca, 37007 Salamanca, Spain

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the research and application of neurokinin-1 receptor antagonists;Journal of Zhejiang University-SCIENCE B;2024-02

2. Fighting Cancer Using Selective Antagonists Targeting the Substance P/Neurokinin-1 Receptor System;Interdisciplinary Cancer Research;2024

3. The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant;International Journal of Molecular Sciences;2023-11-03

4. Combination Therapy of Chemotherapy or Radiotherapy and the Neurokinin-1 Receptor Antagonist Aprepitant: A New Antitumor Strategy?;Current Medicinal Chemistry;2023-05

5. Docking-based virtual screening and molecular dynamic studies to identify new RIOK2 inhibitors;Chemical Papers;2023-02-21